1834 Investment Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-550
Closed -$55K 511
2019
Q3
$55K Hold
550
0.01% 267
2019
Q2
$51K Hold
550
0.01% 283
2019
Q1
$52K Hold
550
0.01% 270
2018
Q4
$35K Hold
550
0.01% 291
2018
Q3
$49K Hold
550
0.01% 278
2018
Q2
$44K Sell
550
-21
-4% -$1.74K 0.01% 284
2018
Q1
$51K Sell
571
-611
-52% -$58.7K 0.01% 273
2017
Q4
$123K Buy
+1,182
New +$133K 0.02% 218

Other funds holding CELG

1834 Investment Advisors's CELG Position: Q4 2019 in Review

1834 Investment Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 550 shares — an estimated $55K sold.

1834 Investment Advisors first reported a position in CELG in Q4 2017 and held it in 8 quarters. The position peaked at $123K in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • 1834 Investment Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • 1834 Investment Advisors sold 550 Celgene Corp shares in Q4 2019, an estimated $55K.
  • 1834 Investment Advisors first reported a position in Celgene Corp in Q4 2017 and held it in 8 quarters.
  • 1834 Investment Advisors's Celgene Corp position peaked at $123K in Q4 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on 1834 Investment Advisors's 13F filing for Q4 2019, filed 27 Jan 2020.